SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Riten Kumar, Shakila P. Khan, Divya-Devi Joshi, Gene R. Shaw, Rhett P. Ketterling, Andrew L. Feldman, Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A, Pediatric Blood & Cancer, 2011, 56, 2
  2. 2
    Toshihiko Imamura, Takashi Sato, Yoko Shiota, Hirokazu Kanegane, Kazuko Kudo, Shinichirou Nakagawa, Hisaya Nakadate, Hisamichi Tauchi, Junji Kamizono, Akira Morimoto, Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan, International Journal of Hematology, 2010, 91, 4, 646

    CrossRef

  3. 3
    Sheila Weitzman, Jorge Braier, Jean Donadieu, R. Maarten Egeler, Nicole Grois, Stephan Ladisch, Ulrike Pötschger, David Webb, James Whitlock, Robert J. Arceci, 2′-chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the histiocyte society, Pediatric Blood & Cancer, 2009, 53, 7
  4. 4
    T. Mittal, M.D.P. Davis, R.B. Lundell, Perianal Langerhans cell histiocytosis relieved by surgical excision, British Journal of Dermatology, 2009, 160, 1
  5. 5
    Barathi Rajendra, Alison Duncan, Richard Parslew, Barry L. Pizer, Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine, Pediatric Blood & Cancer, 2009, 52, 3
  6. 6
    Nataly Apollonsky, Jeffrey M. Lipton, Treatment of Refractory Langerhans Cell Histiocytosis (LCH) With a Combination of 2-Chlorodeoxyadenosine and Cytosine Arabinoside, Journal of Pediatric Hematology/Oncology, 2009, 31, 1, 53

    CrossRef

  7. You have free access to this content7
    Girish Dhall, Jonathan L. Finlay, Ira J. Dunkel, Lawrence J. Ettinger, Stewart J. Kellie, Jeffrey C. Allen, R. Maarten Egeler, Robert J. Arceci, Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine, Pediatric Blood & Cancer, 2008, 50, 1
  8. 8
    Carlos Rodriguez-Galindo, Michael Jeng, Phuong Khuu, M. Beth McCarville, Sima Jeha, Clofarabine in refractory Langerhans cell histiocytosis, Pediatric Blood & Cancer, 2008, 51, 5
  9. 9
    Ceyla Konca, Zübeyde N. Özkurt, Müge Deger, Zeynep Akı, Münci Yağcı, Extranodal multifocal Rosai–Dorfman disease: response to 2-chlorodeoxyadenosine treatment, International Journal of Hematology, 2008, 89, 1, 58

    CrossRef

  10. 10
    Joan Manel Gasent Blesa, Vicente Alberola Candel, Carlos Solano Vercet, Juan Laforga Canales, Christof Semler, M. Rosa Pérez Antolí, Carlos Rodríguez-Galindo, Langerhans cell histiocytosis, Clinical and Translational Oncology, 2008, 10, 11, 688

    CrossRef

  11. 11
    Christine Beneder, Annette Kuhn, Jeannine ImObersteg, Karl Beer, Achim Fleischmann, Michael David Mueller, Isolated Langerhans cell histiocytosis of the vulva: a case report and review of the literature, Gynecological Surgery, 2007, 5, 2, 165

    CrossRef

  12. 12
    Y. H. Liu, X. H. Fan, K. Fang, Langerhans' cell histiocytosis with multisystem involvement in an adult, Clinical and Experimental Dermatology, 2007, 32, 6
  13. 13
    Kevin Bradford Hoover, Daniel I. Rosenthal, Henry Mankin, Langerhans cell histiocytosis, Skeletal Radiology, 2006, 36, 2, 95

    CrossRef

  14. 14
    M. Tasso, C. Esquembre, E. Blanco, C. Moscardó, M. Niveiro, A. Payá, Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease) treated with 2-chlorodeoxyadenosine, Pediatric Blood & Cancer, 2006, 47, 5
  15. 15
    Hubert Mottl, Jan Starý, Markéta Cháňová, Michaela Nekolná, Eva Drahokoupilová, Vratislav Šmelhaus, Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine, Leukemia & Lymphoma, 2006, 47, 9, 1881

    CrossRef

  16. 16
    Sheila Weitzman, Jon Pritchard, Getting there? Salvage therapy for refractory Langerhans cell histiocytosis in children, European Journal of Cancer, 2005, 41, 17, 2592

    CrossRef

  17. 17
    F. Bernard, C. Thomas, Y. Bertrand, M. Munzer, J. Landman Parker, M. Ouache, V. Minard Colin, Y. Perel, P. Chastagner, C. Vermylen, J. Donadieu, Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction, European Journal of Cancer, 2005, 41, 17, 2682

    CrossRef

  18. 18
    Rima F. Jubran, Araz Marachelian, Frederick Dorey, Marcio Malogolowkin, Predictors of outcome in children with Langerhans cell histiocytosis, Pediatric Blood & Cancer, 2005, 45, 1
  19. 19
    Kimo C. Stine, Robert L. Saylors, Suzanne Saccente, Kenneth L. McClain, David L. Becton, Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis, Pediatric Blood & Cancer, 2004, 43, 1
  20. 20
    Carlos Rodriguez-Galindo, Kathleen J. Helton, Niria D. S??nchez, Martha Rieman, Michael Jeng, Winfred Wang, Extranodal Rosai-Dorfman Disease in Children, Journal of Pediatric Hematology/Oncology, 2004, 26, 1, 19

    CrossRef

  21. 21
    A. C. Chu, Histiocytoses,